SUCLG2 Antibodies

Santa Cruz Biotechnology offers a broad range of SUCLG2 monoclonal antibodies for research focused on understanding SUCLG2 protein function. SUCLG2 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SUCLG2, or succinyl-CoA ligase, functions as a key enzyme in the citric acid cycle, playing a vital role in energy metabolism by catalyzing the conversion of succinyl-CoA to succinate. SUCLG2 maintains cellular energy homeostasis and has been linked to various metabolic disorders. Research focusing on SUCLG2 continues to reveal new insights into metabolic diseases and potential therapeutic approaches. Scientists worldwide rely on SUCLG2 monoclonal antibodies to advance their metabolic research projects. Understanding SUCLG2 regulation and function opens new possibilities for therapeutic development. SUCLG2 research using high-quality monoclonal antibodies from Santa Cruz Biotechnology enables scientists to make meaningful contributions to metabolic disease research and treatment strategies.